Tweet
<img alt="" height="1" width="1" />
Firm: FDA needs more time to review surgery drug
USA TODAY
Drugmaker Merck & Co. said Friday that U.S. regulators have delayed a decision on whether to approve a drug, already rejected once, for helping anesthetized patients "wake up" after surgery. The world's third-biggest drugmaker said the Food and Drug ...
Merck anesthesia-reversal agent faces new delayReuters
Merck hit with delay on FDA review of top drug prospectFierceBiotech
Merck: FDA Extends Review of Sugammadex by 3 MonthsFox Business
all 6 news articles »
More...